Device Ingevity Mri_crm

Ingevity Mri

Payments companies reported to CMS as associated with Ingevity Mri. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$129Kassociated payments (2023-2025)
474clinicians with associated payments
1company reporting

By year

2023 $6,804
2024 $24K
2025 $99K

Payments reported as associated with Ingevity Mri, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $101K
Cardiovascular Disease $6,876
Internal Medicine $5,635
Hospitalist $2,092
Interventional Cardiology $1,153
Family $869

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Ingevity Mri

These are the largest totals companies reported as associated with Ingevity Mri. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Apoor Patel Sugar Land, TX Clinical Cardiac Electrophysiology $25,347.40
Gaurav Upadhyay Chicago, IL Clinical Cardiac Electrophysiology $18,326.41
Daniel Friedman Durham, NC Clinical Cardiac Electrophysiology $14,621.43
Kevin Trulock Indianapolis, IN Clinical Cardiac Electrophysiology $11,572.67
Krishna Kancharla Pittsburgh, PA Clinical Cardiac Electrophysiology $8,160.18
Rajan Shah Stanford, CA Clinical Cardiac Electrophysiology $8,144.63
Robert Schaller Philadelphia, PA Clinical Cardiac Electrophysiology $5,000.00
Iriagbonse Asemota Chicago, IL Internal Medicine $1,351.89
Ahmed Elballat Overland Park, KS Cardiovascular Disease $1,295.83
Alexis Parks Mobile, AL Cardiovascular Disease $1,238.28

Prescribed Ingevity Mri?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.